Bienaime Jean Jacques
Keros Therapeutics, Inc. · Director
Bienaime Jean Jacques is listed in public filings as director. This Bienaime Jean Jacques insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Keros Therapeutics, Inc. (KROS), Ascendis Pharma A/S (ASND), Incyte Corp (INCY), and Immunome, Inc. (IMNM). Investors use Bienaime Jean Jacques's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --16.6k shares | Grant / ExerciseJun 3, 2026 | Disclosure amount unavailable7.1k shares | -- | -- | |
| $78k7.4k shares | Grant / ExerciseJun 3, 2026 | $78.0K7.4k shares | $10.50 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $134k600 shares | BuyMay 29, 2026 | $44.8K200 shares | $223.76 | -- | |
| $178k800 shares | BuyMay 29, 2026 | $44.5K200 shares | $222.30 | -- | |
| $201k900 shares | BuyMay 29, 2026 | $22.4K100 shares | $223.50 | -- | |
| $2.2M22.8k shares | Grant / ExerciseMay 26, 2026 | $1.3M13.1k shares | $97.10 | -- | |
| $015k shares | Grant / ExerciseMay 26, 2026 | $1.3M15k shares | $84.53 | -- | |
| $96k400 shares | BuyMay 26, 2026 | $47.9K200 shares | $239.37 | -- | |
| $47k200 shares | BuyMay 26, 2026 | $47.2K200 shares | $236.24 | -- | |
| $899k43.4k shares | BuyMay 15, 2026 | $103.5K5k shares | $20.70 | -- | |
| $100k9.5k shares | BuyMay 15, 2026 | $10.6K1k shares | $10.58 | -- | |
| $99k8.5k shares | BuyApr 15, 2026 | $11.7K1k shares | $11.70 | -- | |
| $828k38.4k shares | BuyMar 11, 2026 | $21.6K1k shares | $21.55 | -- | |
| $828k37.4k shares | BuyMar 10, 2026 | $22.1K1k shares | $22.12 | -- | |
| $84k7.5k shares | BuyMar 9, 2026 | $22.4K2k shares | $11.21 | -- | |
| $646k9.2k shares | Grant / ExerciseJun 10, 2025 | $645.8K9.2k shares | $70.07 | -- | |
| --20.8k shares | Grant / ExerciseJun 10, 2025 | Disclosure amount unavailable2.5k shares | -- | -- | |
| $181k18.9k shares | Grant / ExerciseJun 10, 2025 | $180.5K18.9k shares | $9.57 | -- | |
| --5.5k shares | Grant / ExerciseJun 4, 2025 | Disclosure amount unavailable5.3k shares | -- | -- | |
| $156k10.5k shares | Grant / ExerciseJun 4, 2025 | $155.6K10.5k shares | $14.82 | -- | |
| $342k36.4k shares | BuyJun 3, 2025 | $46.9K5k shares | $9.38 | -- | |
| $244k31.4k shares | BuyMar 25, 2025 | $60.7K7.8k shares | $7.78 | -- | |
| $194k23.6k shares | BuyMar 24, 2025 | $57.5K7k shares | $8.21 | -- | |
| $232k16.6k shares | BuyAug 16, 2024 | $97.6K7k shares | $13.94 | -- | |
| $182k11.3k shares | Grant / ExerciseJun 13, 2024 | $181.8K11.3k shares | $16.04 | -- |